Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$34.33 - $62.11 $116,722 - $211,174
3,400 New
3,400 $7,000
Q4 2021

Jan 18, 2022

SELL
$43.27 - $65.72 $73,559 - $111,724
-1,700 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$53.61 - $67.5 $91,137 - $114,750
1,700 New
1,700 $4,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.